Scoop has an Ethical Paywall
Kick-off Global movement to bust Abbott's monopoly on AID
Today Abbott Laboratories became the target of a
multi-country protest because of its monopoly of the most
important HIV/AIDs drug ever made, Kaletra, is not available
to the people who need it most.
This unique medicine not only prevents HIV/AIDs but it is 96% successful in the treatment of AIDS. However, Abbott keeps the price of this product so high that it is killing people by keeping the medicine out of reach for the most severely affected populations. We are calling for generic competition for this critical AIDs drug immediately.
According to a policy speech made two days ago by U.S. Secretary of State Hillary Clinton, it’s possible for the world to have an “AIDs-free generation” for the first time since the disease was identified. Without global access to this medicine, that statement is nothing but a pipe dream.
Please visit http://www.citizen.org/Kaletra-campaign
for all the news and FAQs on our call for generic
competition of Kaletra.
ENDS
UN News: 10,000 People Feared Buried Under The Rubble In Gaza
Save The Children: Heat-stricken Bangladesh Extends School Closures
Hayden Stephens and Associates: Record Class Action Settlement Gives Hope To 50,000 Australian Junior Doctors
UN News: Healing Page By Page In Earthquake-affected Türkiye
Save The Children: Rate Of Attacks On Healthcare in Gaza Higher Than In Any Other Conflict Since 2018
UN News: Green Light For New Cholera Vaccine, Ukraine Attacks Condemned, Action Against Racism